FLGT

Fulgent Genetics, Inc. operates as a full-service genomic testing company, providing a wide range of diagnostic services focused on oncology, anatomic pathology, infectious and rare diseases, and reproductive health. The company offers over 18,000 single gene tests, 900 rare disease tests, whole genome sequencing, and other specialized genetic testing services. Fulgent also develops therapeutic candidates for cancer treatment, integrating genomic testing with precision medicine. It operates multiple CLIA-certified and CAP-accredited laboratories across the United States.